FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912476605> ?p ?o ?g. }

• W2912476605 endingPage "354" @default.
• W2912476605 startingPage "354" @default.
• W2912476605 abstract "<h3>Importance</h3> Dexamethasone initiated after the first week of life reduces the rate of death or bronchopulmonary dysplasia (BPD) but may cause long-term adverse effects in very preterm infants. Hydrocortisone is increasingly used as an alternative, but evidence supporting its efficacy and safety is lacking. <h3>Objective</h3> To assess the effect of hydrocortisone initiated between 7 and 14 days after birth on death or BPD in very preterm infants. <h3>Design, Setting, and Participants</h3> Double-blind, placebo-controlled randomized trial conducted in 19 neonatal intensive care units in the Netherlands and Belgium from November 15, 2011, to December 23, 2016, among preterm infants with a gestational age of less than 30 weeks and/or birth weight of less than 1250 g who were ventilator dependent between 7 and 14 days of life, with follow-up to hospital discharge ending December 12, 2017. <h3>Interventions</h3> Infants were randomly assigned to receive a 22-day course of systemic hydrocortisone (cumulative dose, 72.5 mg/kg) (n = 182) or placebo (n = 190). <h3>Main Outcomes and Measures</h3> The primary outcome was a composite of death or BPD assessed at 36 weeks’ postmenstrual age. Twenty-nine secondary outcomes were analyzed up to hospital discharge, including death and BPD at 36 weeks’ postmenstrual age. <h3>Results</h3> Among 372 patients randomized (mean gestational age, 26 weeks; 55% male), 371 completed the trial; parents withdrew consent for 1 child treated with hydrocortisone. Death or BPD occurred in 128 of 181 infants (70.7%) randomized to hydrocortisone and in 140 of 190 infants (73.7%) randomized to placebo (adjusted risk difference, −3.6% [95% CI, −12.7% to 5.4%]; adjusted odds ratio, 0.87 [95% CI, 0.54-1.38];<i>P</i> = .54). Of 29 secondary outcomes, 8 showed significant differences, including death at 36 weeks’ postmenstrual age (15.5% with hydrocortisone vs 23.7% with placebo; risk difference, −8.2% [95% CI, −16.2% to −0.1%]; odds ratio, 0.59 [95% CI, 0.35-0.995];<i>P</i> = .048). Twenty-one outcomes showed nonsignificant differences, including BPD (55.2% with hydrocortisone vs 50.0% with placebo; risk difference, 5.2% [95% CI, −4.9% to 15.2%]; odds ratio, 1.24 [95% CI, 0.82-1.86];<i>P</i> = .31). Hyperglycemia requiring insulin therapy was the only adverse effect reported more often in the hydrocortisone group (18.2%) than in the placebo group (7.9%). <h3>Conclusions and Relevance</h3> Among mechanically ventilated very preterm infants, administration of hydrocortisone between 7 and 14 days after birth, compared with placebo, did not improve the composite outcome of death or BPD at 36 weeks’ postmenstrual age. These findings do not support the use of hydrocortisone for this indication. <h3>Trial Registration</h3> Netherlands National Trial Register Identifier:NTR2768" @default.
• W2912476605 created "2019-02-21" @default.
• W2912476605 creator A5000176239 @default.
• W2912476605 creator A5002398864 @default.
• W2912476605 creator A5003464223 @default.
• W2912476605 creator A5011528349 @default.
• W2912476605 creator A5012246480 @default.
• W2912476605 creator A5015206545 @default.
• W2912476605 creator A5032793300 @default.
• W2912476605 creator A5035886368 @default.
• W2912476605 creator A5036020162 @default.
• W2912476605 creator A5039351049 @default.
• W2912476605 creator A5043949580 @default.
• W2912476605 creator A5046357701 @default.
• W2912476605 creator A5060908850 @default.
• W2912476605 creator A5063285113 @default.
• W2912476605 creator A5063706502 @default.
• W2912476605 creator A5066124214 @default.
• W2912476605 creator A5071987242 @default.
• W2912476605 creator A5077117537 @default.
• W2912476605 creator A5089442654 @default.
• W2912476605 date "2019-01-29" @default.
• W2912476605 modified "2023-10-06" @default.
• W2912476605 title "Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation" @default.
• W2912476605 cites W1655615883 @default.
• W2912476605 cites W1857797615 @default.
• W2912476605 cites W1975434115 @default.
• W2912476605 cites W1977621157 @default.
• W2912476605 cites W1996498221 @default.
• W2912476605 cites W1997266616 @default.
• W2912476605 cites W1999893027 @default.
• W2912476605 cites W2004966322 @default.
• W2912476605 cites W2027329450 @default.
• W2912476605 cites W2081988597 @default.
• W2912476605 cites W2111435653 @default.
• W2912476605 cites W2113606273 @default.
• W2912476605 cites W2115713664 @default.
• W2912476605 cites W2152283760 @default.
• W2912476605 cites W2282520777 @default.
• W2912476605 cites W2464072735 @default.
• W2912476605 cites W2478895543 @default.
• W2912476605 cites W2576566866 @default.
• W2912476605 cites W2582323621 @default.
• W2912476605 cites W2583035882 @default.
• W2912476605 cites W2748567996 @default.
• W2912476605 cites W2765280053 @default.
• W2912476605 cites W2769104311 @default.
• W2912476605 cites W2780813443 @default.
• W2912476605 cites W2790554076 @default.
• W2912476605 cites W2791214156 @default.
• W2912476605 cites W2791510998 @default.
• W2912476605 cites W2889940633 @default.
• W2912476605 cites W3148465273 @default.
• W2912476605 cites W4235469056 @default.
• W2912476605 cites W4235980019 @default.
• W2912476605 cites W4237379122 @default.
• W2912476605 cites W4248251600 @default.
• W2912476605 cites W4378195497 @default.
• W2912476605 doi "https://doi.org/10.1001/jama.2018.21443" @default.
• W2912476605 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6439762" @default.
• W2912476605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30694322" @default.
• W2912476605 hasPublicationYear "2019" @default.
• W2912476605 type Work @default.
• W2912476605 sameAs 2912476605 @default.
• W2912476605 citedByCount "78" @default.
• W2912476605 countsByYear W29124766052019 @default.
• W2912476605 countsByYear W29124766052020 @default.
• W2912476605 countsByYear W29124766052021 @default.
• W2912476605 countsByYear W29124766052022 @default.
• W2912476605 countsByYear W29124766052023 @default.
• W2912476605 crossrefType "journal-article" @default.
• W2912476605 hasAuthorship W2912476605A5000176239 @default.
• W2912476605 hasAuthorship W2912476605A5002398864 @default.
• W2912476605 hasAuthorship W2912476605A5003464223 @default.
• W2912476605 hasAuthorship W2912476605A5011528349 @default.
• W2912476605 hasAuthorship W2912476605A5012246480 @default.
• W2912476605 hasAuthorship W2912476605A5015206545 @default.
• W2912476605 hasAuthorship W2912476605A5032793300 @default.
• W2912476605 hasAuthorship W2912476605A5035886368 @default.
• W2912476605 hasAuthorship W2912476605A5036020162 @default.
• W2912476605 hasAuthorship W2912476605A5039351049 @default.
• W2912476605 hasAuthorship W2912476605A5043949580 @default.
• W2912476605 hasAuthorship W2912476605A5046357701 @default.
• W2912476605 hasAuthorship W2912476605A5060908850 @default.
• W2912476605 hasAuthorship W2912476605A5063285113 @default.
• W2912476605 hasAuthorship W2912476605A5063706502 @default.
• W2912476605 hasAuthorship W2912476605A5066124214 @default.
• W2912476605 hasAuthorship W2912476605A5071987242 @default.
• W2912476605 hasAuthorship W2912476605A5077117537 @default.
• W2912476605 hasAuthorship W2912476605A5089442654 @default.
• W2912476605 hasBestOaLocation W29124766051 @default.
• W2912476605 hasConcept C126322002 @default.
• W2912476605 hasConcept C142724271 @default.
• W2912476605 hasConcept C168563851 @default.
• W2912476605 hasConcept C177713679 @default.
• W2912476605 hasConcept C187212893 @default.
• W2912476605 hasConcept C204787440 @default.
• W2912476605 hasConcept C27081682 @default.

• next